perfluorooctane sulfonic acid has been researched along with Bacterial Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, K; Fromme, H; Menzel, J; Mielke, H; Peiser, M; Völkel, W; Weikert, C; Willich, SN; Zepp, F | 1 |
Fan, Z; Qiu, J; Suo, C; Zhou, L | 1 |
2 other study(ies) available for perfluorooctane sulfonic acid and Bacterial Disease
Article | Year |
---|---|
Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response.
Topics: Alkanesulfonic Acids; Antibodies, Bacterial; Bacterial Infections; Bacterial Vaccines; Body Burden; Bottle Feeding; Breast Feeding; Caprylates; Cells, Cultured; Cross-Sectional Studies; Diphtheria Toxoid; Environmental Pollutants; Female; Fluorocarbons; Haemophilus Vaccines; Humans; Immunity, Cellular; Immunogenicity, Vaccine; Infant; Infant Formula; Interferon-gamma; Lymphocytes; Male; No-Observed-Adverse-Effect Level; Tetanus Toxoid; Vaccination | 2020 |
Perfluorooctane sulfonate affects intestinal immunity against bacterial infection.
Topics: Alkanesulfonic Acids; Animals; Bacterial Infections; Cytokines; Disease Models, Animal; Fluorocarbons; Inflammation Mediators; Intestines; Mice; Mucins; Severity of Illness Index; Th17 Cells | 2017 |